Background Currently, the gadolinium retention in the brain after the use of contrast agents is studied by T1‐weighted magnetic resonance imaging (MRI) (T1w) and T1 mapping. The former does not provide easily quantifiable data and the latter requires prolonged scanning and is sensitive to motion. T2 mapping may provide an alternative approach. Animal studies of gadolinium retention are complicated by repeated intravenous (IV) dosing, whereas intraperitoneal (IP) injections might be sufficient. Hypothesis T2 mapping will detect the changes in the rat brain due to gadolinium retention, and IP administration is equivalent to IV for long‐term studies. Study Type Prospective longitudinal. Animal Model A total of 31 Sprague–Dawley rats administered gadodiamide IV (N = 8) or IP (N = 8), or saline IV (N = 6) or IP (N = 9) 4 days per week for 5 weeks. Field strength/sequences A 7 T, T1w, and T2 mapping. Assessment T2 relaxation and image intensities in the deep cerebellar nuclei were measured pre‐treatment and weekly for 5 weeks. Then brains were assessed for neuropathology (N = 4) or gadolinium content using inductively coupled plasma mass spectrometry (ICP‐MS, N = 12). Statistical tests Repeated measures analysis of variance with post hoc Student–Newman–Keuls tests and Hedges' effect size. Results Gadolinium was detected by both approaches; however, T2 mapping was more sensitive (effect size 2.32 for T2 vs. 0.95 for T1w), and earlier detection (week 3 for T2 vs. week 4 for T1w). ICP‐MS confirmed the presence of gadolinium (3.076 ± 0.909 nmol/g in the IV group and 3.948 ± 0.806 nmol/g in the IP group). There was no significant difference between IP and IV groups (ICP‐MS, P = 0.109; MRI, P = 0.696). No histopathological abnormalities were detected in any studied animal. Conclusion T2 relaxometry detects gadolinium retention in the rat brain after multiple doses of gadodiamide irrespective of the route of administration. Evidence Level 1 Technical Efficacy Stage 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.